- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Merck & Company Inc (MRK)
View the Merck & Co Inc stock price live, this page displays NYSE MRK stock exchange data. View the MRK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Merck & Co Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRK quote. (ISIN: US58933Y1055)
What Is the Current Stock Price of Merck?
The Merck & Co Inc stock price is 112.16.
Who Founded Merck?
Merck & Co. traces its roots back to Friedrich Jacob Merck, who acquired a pharmacy in Darmstadt, Germany in 1668. The U.S. company was established in 1891 as the American subsidiary of the German company but was confiscated during World War I and established as an independent American company.
Where is Merck HQ?
While this company has operations around the globe, the current MRK headquarters is located in Kenilworth, New Jersey (U.S.).
When Did Merck Stock Go Public?
Merck has been publicly traded since 1927, when it began trading on the New York Stock Exchange.
When Was the Last Time Merck Stock Split?
Merck's most recent stock split occurred on June 3, 1999. This was a 2-for-1 stock split.
What Stock Exchange Does Merck Trade On?
Merck & Co Inc is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Merck?
The stock symbol for Merck & Co Inc is "MRK."
Is MRK the Same as $MRK?
$MRK is a common way to refer to the Merck & Co Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol.
What Are Merck's Main Business Segments?
Merck operates primarily through two segments: Pharmaceutical (prescription medicines, vaccines, and biologic therapies) and Animal Health (veterinary pharmaceuticals, vaccines, and health management solutions).
What Are Merck's Key Products?
Merck's key pharmaceutical products include Keytruda (cancer immunotherapy), Januvia/Janumet (diabetes), Gardasil (HPV vaccine), and treatments for infectious diseases, cardiovascular diseases, and women's health. Its Animal Health division offers products for livestock and companion animals.
Is Merck the Same as the German Company Merck KGaA?
No, Merck & Co. Inc. (NYSE: MRK) is a U.S.-based company that operates as Merck in North America and as MSD (Merck Sharp & Dohme) outside North America. It is legally separate from the German company Merck KGaA, which operates as EMD in North America. The companies split after World War I.
Is Merck a Good Stock to Buy?
Determining whether Merck, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
What Is the Current Stock Price of Merck?
The Merck & Co Inc stock price is 112.16.
Who Founded Merck?
Merck & Co. traces its roots back to Friedrich Jacob Merck, who acquired a pharmacy in Darmstadt, Germany in 1668. The U.S. company was established in 1891 as the American subsidiary of the German company but was confiscated during World War I and established as an independent American company.
Where is Merck HQ?
While this company has operations around the globe, the current MRK headquarters is located in Kenilworth, New Jersey (U.S.).
When Did Merck Stock Go Public?
Merck has been publicly traded since 1927, when it began trading on the New York Stock Exchange.
When Was the Last Time Merck Stock Split?
Merck's most recent stock split occurred on June 3, 1999. This was a 2-for-1 stock split.
What Stock Exchange Does Merck Trade On?
Merck & Co Inc is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Merck?
The stock symbol for Merck & Co Inc is "MRK."
Is MRK the Same as $MRK?
$MRK is a common way to refer to the Merck & Co Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol.
What Are Merck's Main Business Segments?
Merck operates primarily through two segments: Pharmaceutical (prescription medicines, vaccines, and biologic therapies) and Animal Health (veterinary pharmaceuticals, vaccines, and health management solutions).
What Are Merck's Key Products?
Merck's key pharmaceutical products include Keytruda (cancer immunotherapy), Januvia/Janumet (diabetes), Gardasil (HPV vaccine), and treatments for infectious diseases, cardiovascular diseases, and women's health. Its Animal Health division offers products for livestock and companion animals.
Is Merck the Same as the German Company Merck KGaA?
No, Merck & Co. Inc. (NYSE: MRK) is a U.S.-based company that operates as Merck in North America and as MSD (Merck Sharp & Dohme) outside North America. It is legally separate from the German company Merck KGaA, which operates as EMD in North America. The companies split after World War I.
Is Merck a Good Stock to Buy?
Determining whether Merck, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
111.88
114.54
52 wk Range
73.31
125.14
MRK is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
111.88114.54
52 wk Range
73.31125.14
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.06%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.06%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MRK Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
129.74
Upside
+15.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 15 consecutive years
- Merck & Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Merck & Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Merck & Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Merck & Co receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
19 Buy
10 Hold
0 Sell
Ratings:
29 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 129.74
(+15.67% Upside)
Merck & Company Inc SWOT Analysis
M&A Strategy | Analysts eye Merck's robust balance sheet and M&A potential, with acquisitions in the $1-15 billion range, as key to filling the post-Keytruda revenue gap |
Pipeline Potential | Learn about Merck's promising pipeline, including TROP2 ADC and KRAS inhibitors, as the company seeks to diversify beyond Keytruda and address future growth |
Gardasil Hurdles | Delve into Merck's strategic pause of Gardasil sales in China, impacting 2025 forecasts and raising concerns about inventory management and market dynamics |
Keytruda's Dominance | Explore Merck's reliance on cancer drug Keytruda, its impressive growth, and the looming patent cliff in 2028 that poses significant revenue challenges |
Merck & Company Inc Earnings Call Summary for Q1/2026
- Merck Q1 2026 EPS of -$1.28 beat forecast of -$1.48; revenue hit $16.29B, up 5% YoY, exceeding estimates by 2.52%
- Stock fell 2.61% pre-market to $108.05 despite earnings beat, due to $3.62/share one-time charge from Sedera Therapeutics acquisition
- Oncology segment led by Keytruda drove growth; gross margin declined slightly to 81.9% amid $15.2B operating expenses from acquisition
- Full-year revenue guidance raised to $65.8B-$67B (1%-3% growth); EPS forecast $5.04-$5.16 with positive FX impact expected
- Key risks include Sedera integration costs, declining Gardasil sales in international markets, and regulatory challenges for new approvals
Last Updated: 04/30/2026, 11:08 AM
Read Full TranscriptMerck&Co investor slides for Q1/2026
Last Update: Apr 30, 2026
See full investor slides
Earnings
Latest Release
Apr 30, 2026
EPS / Forecast
-1.28 / -1.48
Revenue / Forecast
16.29B / 15.89B
Compare MRK to Peers and Sector
Metrics to compare | MRK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.0x | 20.0x | −0.5x | |
PEG Ratio | −0.65 | 0.36 | 0.00 | |
Price / Book | 5.3x | 2.8x | 2.6x | |
Price / LTM Sales | 4.2x | 4.1x | 3.2x | |
Upside (Analyst Target) | 20.4% | 0.0% | 47.8% | |
Fair Value Upside | Unlock | 35.0% | 6.7% | Unlock |
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Merck&Co (MRK) Stock Price Today?
The Merck&Co stock price today is 112.16 USD.
What Stock Exchange Does Merck&Co Trade On?
Merck&Co is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Merck&Co?
The stock symbol for Merck&Co is "MRK."
Does Merck&Co Pay Dividends? What’s The Current Dividend Yield?
The Merck&Co dividend yield is 3.06%.
What Is the Merck&Co Market Cap?
As of today, Merck&Co market cap is 277.02B USD.
What Is Merck&Co's Earnings Per Share (TTM)?
The Merck&Co EPS (TTM) is 3.58.
When Is the Next Merck&Co Earnings Date?
Merck&Co will release its next earnings report on Aug 04, 2026.
From a Technical Analysis Perspective, Is MRK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Merck&Co Stock Split?
Merck&Co has split 5 times.
How Many Employees Does Merck&Co Have?
Merck&Co has 74000 employees.
What is the current trading status of Merck&Co (MRK)?
As of May 02, 2026, Merck&Co (MRK) is trading at a price of 112.16 USD, with a previous close of 109.18 USD. The stock has fluctuated within a day range of 111.88 USD to 114.54 USD, while its 52-week range spans from 73.31 USD to 125.14 USD.
What Is Merck&Co (MRK) Price Target According to Analysts?
The average 12-month price target for Merck&Co is 129.74 USD, with a high estimate of 150 USD and a low estimate of 100 USD. 19 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +15.67% Upside potential.
What Is the MRK Premarket Price?
MRK's last pre-market stock price is 112.50 USD. The pre-market share volume is 75,210.00, and the stock has decreased by 3.32, or 3.04%.
What Is the MRK After Hours Price?
MRK's last after hours stock price is 112.39 USD, the stock has decreased by 0.23, or 0.21%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.